3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
71
Neoplasms
64
Prostatic Neoplasms
45
Colorectal Neoplasms
41
Lung Neoplasms
37
Carcinoma, Non-Small-Cell Lung
26
Pancreatic Neoplasms
21
Neoplasm Metastasis
20
Hematologic Neoplasms
20
Head and Neck Neoplasms
19
Urinary Bladder Neoplasms
15
Ovarian Neoplasms
14
Multiple Myeloma
11
Motor Activity
11
Leukemia, Myeloid, Acute
11
Stomach Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
10
Uterine Cervical Neoplasms
9
Triple Negative Breast Neoplasms
9
Glioblastoma
9
Colonic Neoplasms
9
Hematopoietic and Lymphatic System Neoplasm
8
Glioma
8
Gastrointestinal Neoplasms
8
Carcinoma, Renal Cell
8
COVID-19
8
Anxiety Disorders
8
Anatomic Stage I Breast Cancer AJCC v8
8
Rectal Neoplasms
7
Melanoma
7
Interventions
Radiotherapy
2
Exercise
2
Deglutition
2
Cisplatin
2
Carboplatin
2
Brachytherapy
2
Acupuncture Therapy
2
tislelizumab
1
epigallocatechin gallate
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
Tablets
1
Standard of Care
1
Resistance Training
1
Range of Motion, Articular
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Pravastatin
1
Paclitaxel
1
Niacinamide
1
Musculoskeletal Manipulations
1
Lead
1
Hyaluronic Acid
1
Gastropexy
1
Fundoplication
1
Fluorouracil
1
Fibroblast Growth Factor 7
1
Esophagectomy
1
Endoscopy, Digestive System
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Deglutition Disorders
×
Standard of Care
×
Clear all
NCT06192771
2025-03-14
ESSI-SURG
University Health Network, Toronto
Phase NA
Recruiting
40 enrolled